Online citations, reference lists, and bibliographies.
← Back to Search

Impact Of Malignant Mesothelioma In Taiwan: A 27-year Review Of Population-based Cancer Registry Data.

L. Lee, Yu-Yin Chang, J. Wang
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
PURPOSE To describe the epidemiologic characteristics of malignant mesothelioma (MM) in Taiwan; to evaluate the impact of the condition. METHODS The Taiwan Cancer Registry Database was used to retrieve the cases of MM registered from 1979 to 2005. Only cases of histopathologically verified MM were included. For evaluating the impact of MM, the cancer sites of the pleura and peritoneum (ICD-O codes 163 and 158, respectively) were used for statistical analysis and estimation of the expected years of life lost (EYLL). Their survival was calculated by Kaplan-Meier analysis and extrapolated to obtain the EYLL using the Monte Carlo simulation by borrowing information from gender- and age-matched populations in Taiwan. RESULTS A total of 423 cases of MM were included; MM of the pleura and peritoneum accounted for 91% of all cases (387/423). The median survival of pleural and peritoneal MM was 7.6 and 13.5 months for males and females, respectively. The incidence of MM increased during the observation period. A total of 232 males and 155 females diagnosed with MM were used for estimation of EYLL: 14.8 [95% Confidence Interval: 13.1-16.6] life years for males and 13.7 [11.2-16.2] life years for females. CONCLUSION The increasing incidence and significant EYLL for MM were observed for both males and females during 1979-2005 in Taiwan, although under-diagnosis and under-estimation were likely.
This paper references
Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy.
C. Fang (2007)
The burden of illness of cancer: economic cost and quality of life.
M. Brown (2001)
Occupational exposure and respiratory morbidity among asbestos workers in Taiwan.
C. Chen (1992)
Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems
J. Edwards (2000)
Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
Po-Ching Chu (2008)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
Difference in the Incidence Trend of Nasopharyngeal and Oropharyngeal Carcinomas in Taiwan: Implication from Age-Period-Cohort Analysis
C. Hsu (2006)
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
J. Hodgson (2005)
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
V. Rusch (1999)
Cancer epidemiology and control in Taiwan: a brief review.
C. Chen (2002)
Advances in malignant mesothelioma.
B. Robinson (2005)
Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice.
A. Cordony (2008)
The burden of cancer at work: estimation as the first step to prevention
L. Rushton (2007)
The epidemiology of mesothelioma in historical context.
J. C. Mcdonald (1996)
Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis
Ro-Ting Lin (2007)
Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies.
J. Hwang (1999)
Asbestos-related diseases: time for technology sharing
K. Takahashi (2008)
The European mesothelioma epidemic
J. Peto (1999)
[Malignant pleural mesothelioma].
Q. Kong (1983)
Malignant mesothelioma: global incidence and relationship with asbestos.
C. Bianchi (2007)
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)

This paper is referenced by
Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme‐linked immunosorbent assay and immunocytochemistry
Nai-Ding Liao (2012)
Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan
L. Lee (2018)
Assessment of the future mesothelioma disease burden from past exposure to asbestos in ship recycling yards in India.
R. Singh (2020)
Methods to recognize work-related cancer in workplaces, the general population, and by experts in the clinic, a Norwegian experience
S. Langård (2011)
Estimating the incidence of malignant mesothelioma in Vietnam: a pilot descriptive cancer registration study
M. Soeberg (2016)
Asbestos: use, bans and disease burden in Europe
T. Kameda (2014)
Regulation of sex hormone receptors in sexual dimorphism of human cancers.
Daoshan Zheng (2018)
Global Magnitude of Reported and Unreported Mesothelioma
Eun-Kee Park (2011)
Asbestos use and asbestos‐related diseases in Asia: Past, present and future
G. Le (2011)
Malignant mesothelioma in Eastern Asia.
C. Bianchi (2012)
Cancer incidence of Taiwanese shipbreaking workers who have been potentially exposed to asbestos.
W. Wu (2014)
Malignant Peritoneal Mesothelioma
Zhong-Yi Lin (2015)
Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
Ting-Hui Wu (2019)
Semantic Scholar Logo Some data provided by SemanticScholar